These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27465970)

  • 21. Treatment outcome of 600 chemically dependent patients treated in a multimodal inpatient program including aversion therapy and pentothal interviews.
    Smith JW; Frawley PJ
    J Subst Abuse Treat; 1993; 10(4):359-69. PubMed ID: 8105103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prize-based contingency management does not increase gambling.
    Petry NM; Kolodner KB; Li R; Peirce JM; Roll JM; Stitzer ML; Hamilton JA
    Drug Alcohol Depend; 2006 Jul; 83(3):269-73. PubMed ID: 16377101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between waiting time and retention in treatment amongst substance abusers.
    Addenbrooke WM; Rathod NH
    Drug Alcohol Depend; 1990 Nov; 26(3):255-64. PubMed ID: 2265593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does active referral by a doctor or 12-Step peer improve 12-Step meeting attendance? Results from a pilot randomised control trial.
    Manning V; Best D; Faulkner N; Titherington E; Morinan A; Keaney F; Gossop M; Strang J
    Drug Alcohol Depend; 2012 Nov; 126(1-2):131-7. PubMed ID: 22677458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Examining the association between substance use disorder treatment and smoking cessation.
    Shu C; Cook BL
    Addiction; 2015 Jun; 110(6):1015-24. PubMed ID: 25683883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Description of medicosocial profiles of pharmacodependent subjects consulting addictology centres using a computerized database].
    Landreat MG; Vigneau CV; Bronnec MG; Sebille-Rivain V; Venisse JL; Jolliet P
    Encephale; 2011 Dec; 37(6):418-24. PubMed ID: 22137213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Profile of young people attending alcohol and other drug treatment services in Aotearoa, New Zealand: clinical file search.
    Schroder R; Sellman D; Frampton C; Deering D
    Aust N Z J Psychiatry; 2008 Nov; 42(11):963-8. PubMed ID: 18941961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outpatient treatment for cocaine abuse: a controlled comparison of relapse prevention and twelve-step approaches.
    Wells EA; Peterson PL; Gainey RR; Hawkins JD; Catalano RF
    Am J Drug Alcohol Abuse; 1994; 20(1):1-17. PubMed ID: 8192128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug and alcohol abuse inpatients' attitudes about smoking cessation.
    Irving LM; Seidner AL; Burling TA; Thomas RG; Brenner GF
    J Subst Abuse; 1994; 6(3):267-78. PubMed ID: 7703704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations between smoking and pain in early recovery in residential substance use treatment-seekers.
    Blaes SL; Lewis B; Teitelbaum S; Reisfield G; Boissoneault J
    J Subst Use Addict Treat; 2024 May; 160():209311. PubMed ID: 38336263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of coercive and noncoercive pressures to enter drug abuse treatment.
    Marlowe DB; Kirby KC; Bonieskie LM; Glass DJ; Dodds LD; Husband SD; Platt JJ; Festinger DS
    Drug Alcohol Depend; 1996 Oct; 42(2):77-84. PubMed ID: 8889406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Participation of significant others in outpatient behavioral treatment predicts greater cocaine abstinence.
    Higgins ST; Budney AJ; Bickel WK; Badger GJ
    Am J Drug Alcohol Abuse; 1994; 20(1):47-56. PubMed ID: 8192134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences among out-of-treatment drug injectors who use stimulants only, opiates only or both: implications for treatment entry.
    John D; Kwiatkowski CF; Booth RE
    Drug Alcohol Depend; 2001 Oct; 64(2):165-72. PubMed ID: 11543986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving treatment outcomes for pregnant drug-dependent women using low-magnitude voucher incentives.
    Jones HE; Haug NA; Stitzer ML; Svikis DS
    Addict Behav; 2000; 25(2):263-7. PubMed ID: 10795950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age at onset typology in opioid-dependent men: an exploratory study from India.
    De B; Mattoo SK; Basu D
    Am J Addict; 2003; 12(4):336-45. PubMed ID: 14504026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fixed and dynamic predictors of client retention in therapeutic communities.
    Condelli WS; De Leon G
    J Subst Abuse Treat; 1993; 10(1):11-6. PubMed ID: 8383775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quitting among non-treatment-seeking marijuana users: reasons and changes in other substance use.
    Copersino ML; Boyd SJ; Tashkin DP; Huestis MA; Heishman SJ; Dermand JC; Simmons MS; Gorelick DA
    Am J Addict; 2006; 15(4):297-302. PubMed ID: 16867925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An abstinence-oriented program for substance use disorders: poorer outcome associated with opiate dependence.
    Paraherakis A; Charney DA; Palacios-Boix J; Gill K
    Can J Psychiatry; 2000 Dec; 45(10):927-31. PubMed ID: 11190363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
    Rohsenow DJ; Tidey JW; Martin RA; Colby SM; Swift RM; Leggio L; Monti PM
    Addiction; 2017 Oct; 112(10):1808-1820. PubMed ID: 28498504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.